Canada Airway Management Devices Market Analysis Industry Trends and Forecast to 2034: Segmented by (By Type of Device, By Application, By Material Type, By End User, By Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
Canada · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$168.3 MnPlaceholder estimate
Estimate 2025$177.1 Mn8% of the global market
Projected 2034$279.4 Mn 57.8%Adds $102.4 Mn over 9 forecast years
CAGR 2025–20345.2%Faster than 4% of 173 Medical Devices markets here
Canada Airway Management Devices Market Analysis at a glance
Market size, 2025
$177.1 Mn placeholder estimate
Forecast, 2034
$279.4 Mn placeholder estimate
Growth (CAGR), 2025–2034
5.2% placeholder estimate
Years
2024 historical · 2025 base year · 2026–2034 forecast
Segments
Type of device, application, material type and end user (see all)
Key players
Medtronic, Teleflex Inc, Ambu A/S, Smith’s Medical, Inc., Karl Storz SE & Co. KG and 1 more (see all)
Regulator in Canada
Health CanadaSource: Health Canada. Checked 14 Nov 2026.
Active clinical trials
102 in CanadaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Canada. Retrieved 9 Nov 2026.
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The Canada Airway Management Devices Market Executive Summary
Airway management entails the assessment, planning and the application of a variety of medical interventions and tools in order to establish the patency or the restoration of airway for effective oxygenation and ventilation. These procedures are required in patients with a compromised airway, respiratory distress, or failure.
Technological development, the growth in diseases affecting the respiratory system, and the growing number of surgical operations are some factors driving the market for airway management devices. The important factors include the necessity for proper management of the airway and new devices like video laryngoscopes which increase safety of surgical and emergency procedures. The market classified by product type includes infraglottic and supraglottic devices, resuscitators and accessories when key companies are Medtronic and Teleflex. Obstacles include legal framework, cost barriers, and a requirement for specialists. As technologies are advancing in the future, some of the impending trends include less invasiveness in surgeries, making of portable devices and integrating artificial intelligence in the healthcare for enhancing both the patient results and the efficacy of the devices.
Canada Airway Management Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
Canada Airway Management Devices Market Dynamics
Market Growth Drivers
The prevalence of respiratory illnesses such as asthma, COPD, and obstructive sleep apnea warrants proper management of airway in order to facilitate adequate oxygenation. An increase in the number of surgeries as a result of a growing population as well as advancement in medical procedures for patients also significantly drives the demand for devices used during operations such as anaesthesia and management of the airway. Concerning the factors that drive the market growth, it has been noted that an increase in the proportion of people aged 65 and above, the prevalence of life-style related disorders including obesity, the growth in the emergency medical transport services, and an emphasis on pediatric care have equally propelled the market’s growth.
Opportunity
Some of the trends in the airway management devices market include identifying new markets such as Asia-Pacific and Latin Americas because of improvements in healthcare and increased purchasing power among patients. Opportunities are present in areas like newer and improved video laryngoscopes, smart monitoring, minimal access options, and disposable products. Also, the ageing apart from having a large population is a specialty care while the specialty care which is pediatrics also shows promising growth.
Market Restraints
Expense, restricted coverage policies, and regulatory requirements can hinder the incorporation of improved airway management devices, particularly in the developing world. Further, the lack of qualified specialists, issues related to risks in potential complications, and restricted acceptance of such technologies can also affect market growth and the usage of these technologies.
Competitive Landscape for Airway Management Devices Market in Canada
June 2025, Airway Management, leading innovator in sleep therapy products and manufacturer of the most globally researched custom oral appliances, announced the launch of its Morf Nasal CPAP Mask. Designed to enhance comfort and sustainability, this revolutionary mask incorporates a silicone-free biodegradable seal, setting a new standard in the industry.
May 2025, Launch of ALNEST N1 Silent mask. Intended for all patients requiring non-invasive ventilation at home, and more particularly for patients treated with CPAP for Sleep Apnea, this mask has been designed to provide maximum comfort, stability and ease of use. Its landmarks and its silent leak system offer an optimal therapeutic experience.
March 2025, BHV Partners launched Conus Airway, a startup focused on developing medical devices for respiratory tract anesthesia and surgery. These devices enable simultaneous endotracheal dilation and ventilation, aiming to reduce surgical risks, improve outcomes, minimize cross-contamination, and enhance efficiency in managing respiratory surgeries.
May 2021, Olympus received FDA 510(k) clearance for its Airway Mobilescopes (MAF-TM2, MAF-GM2, and MAF-DM2), allowing healthcare providers to perform various upper and lower airway management procedures. These devices are designed for anesthesiologists, pulmonologists, and critical care providers, offering benefits such as portability, digital capture capability, and a compact all-in-one design.
May 2021, Medtronic announced the U.S. commercial launch of the SonarMed airway monitoring system. The system utilises acoustic technology to check for endotracheal tube (ETT) obstruction and verify position in real-time.
Mergers and Acquisitions
March 2024, Medline, a market-leading manufacturer and supplier of medical supplies and solutions, announced successful acquisition of the manufacturing rights and intellectual property of AG Cuffill from Hospitech Respiration Ltd. The compact and intuitive syringe-like device provides an accurate solution for measuring both pressure and volume of airway cuffs in all clinical settings.
October 2025, The Private Equity team advised SunMed Group Holdings d/b/a AirLife, a portfolio company of Frazier Healthcare Partners, on the completion of its acquisition of Avanos Medical, including the BALLARD, MICROCUFF and endOclear product lines.
September 2025, Inogen Completes Acquisition of Physio-Assist. Acquisition expands inogen’s global respiratory care presence by addressing the sizeable, growing and underserved airway clearance market opportunity.
March 2025, Sunmed was to acquire respiratory & anaesthesia consumables business of Vyaire medical.
Healthcare Policies and Regulatory Landscape for Airway Management Devices Market in Canada
Airway Management Devices in Canada: rules, payment and research
Health Canada licenses Class II, III and IV medical devices; Class I devices are sold by companies that hold an establishment licence.[1] Each province and territory runs public health insurance under the Canada Health Act, which covers medically necessary hospital and doctor services.[2] ClinicalTrials.gov lists 102 studies on Airway Management Devices that are recruiting, active or about to start in Canada.[3]
[3]ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Canada. Retrieved 9 Nov 2026.
Policy changes and Reimbursement scenario
Regulatory approval procedures in developed markets such as the US and Europe demand thorough testing, and this prolongs product development and escalates costs. Standards also change over time, which means that manufacturers will always have to incur costs in order to meet the prevailing ones. Reimbursement has its policies; where there is a favourable coverage policy advocated for establishment of post operative care in fully developed health systems, the absence of such framework in developing markets denies the product due to exorbitant out of pocket expense. Furthermore, possible future adjustments to reimbursement rates and the transition to value-based care initiatives may necessitate cost justification from manufacturers in order to continue growing a lucrative market.
8.2 Government Initiatives / Intervention programs
The airway management devices market is segmented into several key categories, which help in understanding the various dynamics and opportunities within the industry. Here’s a detailed overview of the market segmentation:
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
Also active in this area, from free public records
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in Airway Management Devices right now, from free public sources.
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov,
World Bank.
Fetched 9 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Public data, with sources
Airway Management Devices in context
Canada compared
Health spending per person: 6,378 US$ per person (2024). World: 1,317 US$ per person (2023).[1]
Doctors: 2.82 per 1,000 people (2023). World: 1.86 per 1,000 people (2022).[2]
People aged 65 and over: 20.3% of people (2025). World: 10.4% of people (2025).[3]
[1]World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.
How big is the Airway Management Devices market in Canada?
Placeholder estimate: about $177.1 Mn in 2025, rising to about $279.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Airway Management Devices market in Canada growing?
Placeholder estimate: about 5.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Airway Management Devices market report cover?
The report splits the market by type of device (Supraglottic Airway Management Devices, Infraglottic Airway Management Devices, Laryngoscopes, Bronchoscope/Intubation Scopes and more), application (Anaesthesia, Emergency Medicine), material type (PVC (Polyvinyl Chloride) Airway Devices, Silicone Airway Devices) and end user (Hospitals, Homecare, Ambulatory Surgical Centres (ASCs)).
Who are the key players in the Airway Management Devices market?
Key players include Medtronic, Teleflex Inc, Ambu A/S, Smith’s Medical, Inc., Karl Storz SE & Co. KG and Flexicare (Group) Limited.
What is driving the Airway Management Devices market?
The prevalence of respiratory illnesses such as asthma, COPD, and obstructive sleep apnea warrants proper management of airway in order to facilitate adequate oxygenation.
Who regulates Airway Management Devices in Canada?
Health Canada licenses Class II, III and IV medical devices; Class I devices are sold by companies that hold an establishment licence. Source: Health Canada. Checked 14 Nov 2026.
How is healthcare paid for in Canada?
Each province and territory runs public health insurance under the Canada Health Act, which covers medically necessary hospital and doctor services. Source: Health Canada. Checked 14 Nov 2026.
How many clinical trials on Airway Management Devices are running in Canada?
102 studies are recruiting, active or about to start in Canada, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Canada. Retrieved 9 Nov 2026.
How much research is published on Airway Management Devices?
PubMed lists 10,997 papers on Airway Management Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 9 Nov 2026.